Therapeutic Drug Monitoring · 2000 · 162 citations · 12 references
PharmacyPharmacologyToxicologyBiochemical ToxicologyHepatotoxicologyPharmaceutical ToxicologyCellular ToxicologyCytotoxicity AssessmentCytotoxicity EvaluationHepatotoxicity MechanismsMechanisms Of Toxic InjuryMolecular Mechanisms Of ToxicityChemical PropertiesCyanobacterial Toxin Liver InjuryCytotoxicity AssaysHepatotoxicity Of Algal ToxinsNeurotoxicity Of Cyanobacteria
This paper describes the natural occurrence of the toxin, cylindrospermopsin, in two species of cyanobacteria found in Australia. The structure and chemical properties of this compound are described along with a nontoxic analog of cylindrospermopsin. The results of both intraperitoneal (IP) and oral dosing of mice show that hepatotoxicity is the main effect of cylindrospermopsin in vivo, but that a thrombohemorrhagic phenomenon is observed in a proportion of dosed animals. It has been shown that the toxin can be metabolized in vivo and that a bound metabolite occurs in the liver. Cytotoxicity experiments using cell cultures show that cylindrospermopsin is more cytotoxic to isolated rat liver hepatocytes than to other cell types. Risk assessment calculations show that guideline values for cylindrospernopsin in drinking water should lie in the low microgram per liter range.
12
Peter Hawkins, Maria T. C. Runnegar, Alan Jackson et al. · Applied and Environmental Microbiology · 1985 · 600 citations · Full text
Isolation of cylindrospermopsin from a cyanobacterium Umezakia natans and its screening method
Ken‐ichi Harada, Ikuko I. Ohtani, Kayoko Iwamoto et al. · Toxicon · 1994 · 339 citations
Susan Byth · The Medical Journal of Australia · 1980 · 287 citations